全文获取类型
收费全文 | 7473篇 |
免费 | 1027篇 |
国内免费 | 190篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 385篇 |
妇产科学 | 172篇 |
基础医学 | 783篇 |
口腔科学 | 60篇 |
临床医学 | 1182篇 |
内科学 | 1220篇 |
皮肤病学 | 77篇 |
神经病学 | 129篇 |
特种医学 | 131篇 |
外国民族医学 | 1篇 |
外科学 | 2749篇 |
综合类 | 583篇 |
现状与发展 | 4篇 |
一般理论 | 6篇 |
预防医学 | 400篇 |
眼科学 | 128篇 |
药学 | 407篇 |
1篇 | |
中国医学 | 58篇 |
肿瘤学 | 202篇 |
出版年
2024年 | 5篇 |
2023年 | 158篇 |
2022年 | 160篇 |
2021年 | 270篇 |
2020年 | 284篇 |
2019年 | 345篇 |
2018年 | 331篇 |
2017年 | 310篇 |
2016年 | 286篇 |
2015年 | 275篇 |
2014年 | 421篇 |
2013年 | 477篇 |
2012年 | 414篇 |
2011年 | 450篇 |
2010年 | 412篇 |
2009年 | 462篇 |
2008年 | 476篇 |
2007年 | 322篇 |
2006年 | 332篇 |
2005年 | 257篇 |
2004年 | 236篇 |
2003年 | 222篇 |
2002年 | 173篇 |
2001年 | 353篇 |
2000年 | 327篇 |
1999年 | 221篇 |
1998年 | 60篇 |
1997年 | 81篇 |
1996年 | 66篇 |
1995年 | 54篇 |
1994年 | 57篇 |
1993年 | 37篇 |
1992年 | 33篇 |
1991年 | 25篇 |
1990年 | 17篇 |
1989年 | 15篇 |
1988年 | 21篇 |
1987年 | 12篇 |
1986年 | 14篇 |
1985年 | 36篇 |
1984年 | 51篇 |
1983年 | 24篇 |
1982年 | 21篇 |
1981年 | 23篇 |
1980年 | 15篇 |
1979年 | 14篇 |
1978年 | 6篇 |
1977年 | 8篇 |
1975年 | 5篇 |
1907年 | 4篇 |
排序方式: 共有8690条查询结果,搜索用时 15 毫秒
81.
中厚供皮区回植自体刃厚皮片的疗效观察 总被引:1,自引:0,他引:1
目的 探讨中厚供皮区创面回植自体刃厚皮片的临床疗效。方法 选择2004年1月~2007年4月43例各种原因致功能部位全层皮肤缺损行中厚皮移植的患者,按中厚供区处理方法分为A组(回植刃厚皮片组,20例)和B组(常规处理组,23例),对两组创面的愈合时间、感染情况及愈合后瘢痕形成等情况进行比较。结果A组平均愈合时间(11.2±3.2)d,创面感染1例,愈后瘢痕少;B组平均愈合时间(21.5±6.4)d,创面感染5例,愈后瘢痕明显。两组愈合时间比较有显著统计学意义(P〈0.01)。结论中厚供皮区回植自体刃厚皮片,可加速创面愈合,减少瘢痕形成。 相似文献
82.
目的:探讨多种因素对AID治疗结局的影响。方法:回顾2008年11月~2010年5月在生殖中心实施AID助孕治疗的418名妇女639个治疗周期的病例,综合分析不孕妇女的年龄、输卵管情况、治疗周期、促排卵用药及授精次数等因素对AID治疗妊娠结局的影响。结果:AID周期妊娠率为34.90%(223/639),例数妊娠率为53.34%(223/418)。临床妊娠率与女方年龄、是否合并输卵管因素、授精与排卵时间等有一定关系。排卵前后短时内单次授精的平均妊娠率反而高于排卵前后双次授精。639个AID周期中,随治疗周期的增加累计妊娠率随之增高,但周期妊娠率下降,第1~3周期临床妊娠率依次为37.08%、31.98%、21.95%。AID促排卵周期妊娠率与自然周期无差异(34.02%、35.63%)。结论:不孕妇女的年龄、输卵管情况及授精时机的掌握是影响供精人工授精成功率的重要因素。对超过3周期仍不孕者,可考虑改行供精体外授精-胚胎移植进行助孕。 相似文献
83.
84.
目的:探讨造血生长因子(HGFs)对健康供者外周血干细胞(PBSC)的动员作用,并比较粒细胞集落刺激因子(G-CSF)单用及G-CSF联合粒-巨噬细胞集落刺激因子(GM-CSF)的动员效果.方法:52例健康供者分成G-CSF单用组(34例)及与GM-CSF合用组(18例),分别采用G-CSF(5 μg·kg-1·d-1)及G-CSF(3 μg·kg-1·d-1)+GM-CSF(2 μg·kg-1·d-1),连续皮下注射5~6 d动员,采集PBSC.动员前后动态检测外周血及采集物MNC、CD34+细胞、CFU-GM计数.52例血液病患者接受上述供体动员之PBSC并行异基因PBSC移植(Allo-PBSCT).结果:动员后CD34+细胞及CFU-GM分别较动员前增加10.83及8.7倍,并在第5~6天达到高峰;G-CSF单用及与GM-CSF合用均可有效动员CD34+细胞和CFU-GM,但合用较单用更有效(P<0.05);所有患者接受Allo-PBSCT后均满意获得造血重建;随访观察至今应用HGFs对健康供者无明显不良反应.结论:采用中小剂量G-CSF单用和与GM-CSF合用均能安全、有效动员健康供者PBSC,但以合用更为有效. 相似文献
85.
本文采用SPRIA和ELISA法测定了128名献血员和49名化验员的五项血清学指标及SGPT。结果表明献血员中HBV感染率城市高于农村,男高于女,AB血型者高于其它血型(P<0.01)。化验员HBV感染率(51.02%)高于献血员(48.33%)(RR=1.05),HBV的感染随工龄增长而升高。 相似文献
86.
Abdulrahman Alshalani Lisa van Manen Margit Boshuizen Robin van Bruggen Jason P. Acker Nicole P. Juffermans 《Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie》2022,49(2):98
BackgroundObservational studies suggest that sex-mismatched transfusion is associated with increased mortality. Mechanisms driving mortality are not known but may include endothelial activation. The aim of this study is to investigate the effects of sex-mismatched red blood cell (RBC) transfusions on endothelial cell activation markers in critically ill patients.Study Design and MethodsIn patients admitted to the intensive care unit who received a single RBC unit, blood samples were drawn before (T<sub>0</sub>), 1 h after (T<sub>1</sub>), and 24 h after transfusion (T<sub>24</sub>) for analysis of soluble syndecan-1, soluble intercellular adhesion molecule-1, soluble thrombomodulin (sTM), von Willebrand factor antigen, interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNFα). Changes in the levels of these factors were compared between sex-matched and sex-mismatched groups.ResultsOf 69 included patients, 32 patients were in the sex-matched and 37 patients were in the sex-mismatched group. Compared to baseline, sex-matched transfusion was associated with significant reduction in sTM level (p value = 0.03). Between-group comparison showed that levels of syndecan-1 and sTM were significantly higher in the sex-mismatched group compared to the sex-matched group at T<sub>24</sub> (p value = 0.04 and 0.01, respectively). Also, TNFα and IL-6 levels showed a statistically marginal significant increase compared to baseline in the sex-mismatched group at T<sub>24</sub> (p value = 0.06 and 0.05, respectively), but not in the sex-matched group.DiscussionTransfusion of a single sex-mismatched RBC unit was associated with higher syndecan-1 and sTM levels compared to transfusion of sex-matched RBC unit. These findings may suggest that sex-mismatched RBC transfusion is associated with endothelial activation. 相似文献
87.
Limited organ supply has led to greater use of liver allografts with higher donor risk indices (DRI) and/or donated after cardiac death (DCD). DCD status is associated with acute kidney injury after liver transplantation; however, less is known about the association between donor quality and end‐stage renal disease (ESRD). Using SRTR data, we assembled a cohort of liver transplant recipients from 2/2002 to 12/2010. We fit multivariable Cox regression models for ESRD. Model 1 included total DRI; model 2 included components of DRI, including DCD, as separate variables. Forty thousand four hundred and sixty‐three liver transplant recipients were included. Median DRI was 1.40 (IQR 1.14, 1.72); 1822 (5%) received DCD livers. During median follow‐up of 3.93 years, ESRD occurred in 2008 (5%) and death in 11 075 (27%) subjects. There was a stepwise increase in ESRD risk with higher DRI (DRI ≥1.14 and <1.40: HR 1.17, P = 0.06; DRI ≥1.40 and <1.72: HR 1.29, P = 0.003; DRI ≥1.72: HR 1.39, P < 0.001, compared with DRI <1.14). Adjusting for DRI components separately, DCD status was most strongly associated with ESRD (HR 1.40, P = 0.008). Higher DRI is associated with ESRD after liver transplantation, driven in part by DCD status. Donor quality is an important predictor of long‐term renal outcomes in liver transplant recipients. 相似文献
88.
T. Yamada K. Tanaka K. Uryuhara K. Ito Y. Takada S. Uemoto 《American journal of transplantation》2008,8(4):847-853
We developed an algorithm of graft selection in which left lobe donation is considered primarily if the graft-to-recipient weight ratio (GRWR) is estimated to be greater than 0.6% in preoperative volumetry with utilization of a hemi-portocaval shunt (HPCS) based on portal vein pressure (PVP) more than 20 mmHg at the time of laparotomy. A total of 11 consecutive adult living donor liver transplantations with small-for-size graft according to our graft selection algorithm were performed between December 2005 and August 2007. Ten patients required HPCS using a vein graft all survived without small-for-size syndrome (SFSS) and shunt complications with a median follow-up of 296 days. One patient without HPCS died of chronic vascular rejection. In all cases, PVP were regulated successfully under 20 mmHg by HPCS. Graft volume reached in mean 84.3% of standard liver volume in right lobe grafts and mean 95.4% in left lobe grafts at 3 months after liver transplantation. Actuarial rate of shunt patency at 1, 3, 6 months and 1 year were 80%, 55%, 26% and 20%, respectively. Selective HPCS based on PVP is an effective procedure and results in excellent patient and graft survival with avoidance of SFSS in grafts greater than 0.6% of GRWR. 相似文献
89.
90.